Ads
related to: danaher stock news release this weeksuperstockscreener.com has been visited by 10K+ users in the past month
wsj.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
On Tuesday, Danaher Corp (NYSE:DHR) reported third-quarter sales of $5.79 billion, up 3% year-over-year, beating the consensus of $5.59 billion. Guidance: Danaher reaffirms that in fiscal year ...
On Tuesday, Danaher Corp (NYSE:DHR) reported third-quarter sales of $5.79 billion, up 3% year-over-year, beating the consensus of $5.59 billion. Non-GAAP core revenue increased by 0.5%, compared ...
When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really... Danaher (NYSE:DHR) sheds 4.6% this week, as yearly returns fall more in ...
Danaher (DHR) delivered earnings and revenue surprises of 14.29% and 8.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Danaher (DHR) outperforms its industry and the S&P 500 year to date on solid financial performances, buyout gains, solid product demand, shareholder-friendly policies and other factors.
On September 12, 2023, author and vlogger John Green released a video [59] highlighting these ethical concerns and calling on his community to reach out to Danaher. [60] [61] One week later, Cepheid and Danaher announced a 20% price reduction for their Xpert MTB/RIF TB test cartridge, from $9.98 to $7.97 in high TB-burden countries. However ...
In the latest trading session, Danaher (DHR) closed at $274.23, marking a -0.11% move from the previous day.
Danaher (DHR), with an 11% rise in shares in the past three months, gains from solid product offerings, the pandemic-induced demand and focus on innovation. Inorganic activities too have been aiding.
Ads
related to: danaher stock news release this weeksuperstockscreener.com has been visited by 10K+ users in the past month
wsj.com has been visited by 10K+ users in the past month